AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Dicyclomine Hydrochloride
9 registrations across 2 African markets— 5 active
Markets with Dicyclomine Hydrochloride
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Trigan D Injection Injection | 🇿🇲Zambia | Cadila Pharmaceuticals Limited | active | Jul 2030 |
| NOMOCRAMP TABLETS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| GAREC-DICYCLOMINE CO GEL | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Dec 2023 |
| NOMOCRAMP SYRUP | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Nov 2022 |
| GASTROPIN | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Nov 2022 |
| ALUMAG D | 🇿🇦South Africa | Pharmacorp (Pty) Ltd | active | Jan 1900 |
| CO-GEL | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| MEDICYCLOMINE SYRUP | 🇿🇦South Africa | Brunel Laboratoria (Pty) Ltd | active | Jan 1900 |
| ASIC | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
Dicyclomine Hydrochloride in Africa — Regulatory Overview
Dicyclomine Hydrochloride is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 5 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.